FDC Stock Reaches All-Time High, Outperforms Sector and Sensex Amidst Pandemic Challenges

FDC, a midcap pharmaceutical company, has recently seen a surge in its stock price, reaching an all-time high on January 18th, 2024. The stock is currently trading at Rs 432, which is 3.57% away from its 52-week high. This positive performance has caught the attention of investors and market analysts. According to MarketsMOJO, a leading financial research and analysis firm, the stock call for FDC is 'Hold'. This indicates that while the stock has shown promising growth, it is not recommended for immediate buying or selling. In today's trading session, FDC has underperformed the sector by -0.96%. The stock touched an intraday low of Rs 405.9, showing a decline of -3.13%. However, FDC is still trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend. In the past year, FDC has outperformed the Sensex, with a growth of 65.77% compared to the Sensex's 16.51%. This showcases the company's strong performance and potential for future growth. FDC, with its focus on the pharmaceutical industry, has been able to maintain a steady growth trajectory despite the challenges posed by the pandemic. With its strong financials and promising performance, FDC is definitely a stock to watch out for in the midcap segment.